首页> 外文期刊>World Journal of Gastroenterology >Alpha-fetoprotein triggers hepatoma cells escaping from immune surveillance through altering the expression of Fas/FasL and tumor necrosis factor related apoptosis-inducing ligand and its receptor of lymphocytes and liver cancer cells.
【24h】

Alpha-fetoprotein triggers hepatoma cells escaping from immune surveillance through altering the expression of Fas/FasL and tumor necrosis factor related apoptosis-inducing ligand and its receptor of lymphocytes and liver cancer cells.

机译:甲胎蛋白通过改变Fas / FasL的表达以及与肿瘤坏死因子相关的凋亡诱导配体及其淋巴细胞和肝癌细胞的受体来触发逃避免疫监视的肝癌细胞。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To investigate the mechanism of alpha-fetoprotein (AFP) in escaping from the host immune surveillance of hepatoc-ellular carcinoma. METHODS: AFP purified from human umbilical blood was administrated into the cultured human lymphoma Jurkat T cell line or hepatoma cell line, Bel7402 in vitro. The expression of tumor necrosis factor related apoptosis-inducing ligand (TRAIL) and its receptor (TRAILR) mRNA were analyzed by Northern blot and Western blot was used to detect the expression of Fas and Fas ligand (FasL) protein. RESULTS: AFP (20 mg/L) could promote the expression of FasL and TRAIL, and inhibit the expression of Fas and TRAILR of Bel7402 cells. For Jurkat cell line, AFP could suppress the expression of FasL and TRAIL, and stimulate the expression of Fas and TRAILR. AFP also could synergize with Bel7402 cells to inhibit the expression of FasL protein and TRAIL mRNA in Jurkat cells. The monoclonal antibody against AFP (anti-AFP) could abolish these functions of AFP. CONCLUSION: AFP is able to promote the expression of FasL and TRAIL in hepatoma cells and enhance the expression of Fas and TRAILR in lymphocytes. These could elicit the escape of hepatocellular carcinoma cells from the host's lymphocytes immune surveillance.
机译:目的:探讨甲胎蛋白(AFP)逃逸宿主对肝细胞癌的免疫监测的机制。方法:将从人脐带血中纯化的AFP体外施用至培养的人淋巴瘤Jurkat T细胞系或肝癌细胞系Bel7402中。用Northern印迹分析肿瘤坏死因子相关的凋亡诱导配体(TRAIL)及其受体(TRAILR)mRNA的表达,并用Western blot检测Fas和FasL配体的表达。结果:AFP(20 mg / L)能促进FasL和TRAIL的表达,抑制Bel7402细胞Fas和TRAILR的表达。对于Jurkat细胞系,AFP可以抑制FasL和TRAIL的表达,并刺激Fas和TRAILR的表达。 AFP还可以与Bel7402细胞协同作用,以抑制Jurkat细胞中FasL蛋白和TRAIL mRNA的表达。抗AFP的单克隆抗体(抗AFP)可以废除AFP的这些功能。结论:AFP能够促进肝癌细胞FasL和TRAIL的表达,并能促进淋巴细胞Fas和TRAILR的表达。这些可能促使肝细胞癌细胞脱离宿主的淋巴细胞免疫监控。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号